IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis.
about
Immune response and immunopathology during toxoplasmosisInterleukin-27: balancing protective and pathological immunityThe myeloid receptor PILRβ mediates the balance of inflammatory responses through regulation of IL-27 productionInduction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.IL-27 promotes T cell-dependent colitis through multiple mechanisms.The WSX-1 pathway restrains intestinal T-cell immunityTranscription factor T-bet regulates intraepithelial lymphocyte functional maturation.Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.Dendritic cells change IL-27 production pattern during childhood.Resident bacteria-stimulated IL-10-secreting B cells ameliorate T cell-mediated colitis by inducing Tr-1 cells that require IL-27-signalingResistin-like molecule α promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation.Double-Negative αβ T Cells Are Early Responders to AKI and Are Found in Human KidneyInterleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis.CD4(+) T-cell subsets in intestinal inflammationInflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection.Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in miceIntestinal effector T cells in health and disease.Interleukin 27: a double-edged sword for offense and defense.Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium.Genetics of childhood-onset inflammatory bowel disease.Animal models of IBD: linkage to human disease.Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice.Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells.Regulation and Immune Function of IL-27.Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells.Deletion of intestinal epithelial cell STAT3 promotes T-lymphocyte STAT3 activation and chronic colitis following acute dextran sodium sulfate injury in mice.Interleukin-27 enhances the production of tumour necrosis factor-α and interferon-γ by bone marrow T lymphocytes in aplastic anaemia.Protective function of interleukin 27 in colitis-associated cancer via suppression of inflammatory cytokines in intestinal epithelial cells.Intravenous Injection of Endogenous Microbial Components Abrogates DSS-Induced Colitis
P2860
Q24612341-CF917615-9FC5-4907-B3F3-820C1B6B9BB7Q26830400-5C82F926-FA3C-4B43-83D8-7C4C3EF39124Q28730911-1EFCA6FD-953C-4381-BD3B-7B531874B4B0Q34154099-22DC5DD1-1CF6-4878-AA39-E5E057427E0DQ34501413-3B44F295-229B-45A1-9386-01F33512D51FQ34538706-BB7ED9AE-18C8-4F01-A8FA-A5D881C089BFQ34873216-2538557A-9DBD-4983-A388-04E7F63F16A8Q35592657-4005A32D-E878-4732-814C-3328EA222109Q35657026-6D4E6196-C1A7-4318-8980-BD06740CE650Q35664427-8673E887-65B5-4B0B-A9C0-D8819FB006B7Q36697472-31B4DD98-715E-48A5-BE5F-708452E006C1Q36746046-E9C243D1-5618-4E64-AB42-53AC96ADA494Q36761383-74C97D62-7351-4655-82BD-0E405E6E6D5CQ37076943-B1F8A42F-E0C1-45A3-A479-5B763E6942F8Q37127389-EA5CEE08-EAF1-499A-831D-6C311719961AQ37577227-C4BC46E8-8114-4E0A-A79C-623A55E260FEQ37600191-ED556A40-A5B2-43A7-BD67-B81206B85D0FQ37607910-49A92772-AE31-4BA3-9A61-FD3B91CD7DCAQ37713389-B6E24CE5-85C0-4501-BFBE-229E427D303EQ37788639-53CA363C-E550-4A91-BF28-B4BD863B3D9CQ37791260-83DB3505-B524-47CB-AE73-6CCA5A3D7270Q38172801-1622037B-111B-4A45-B431-F784C98E79ECQ38795605-0DE70231-AEF6-4864-AA55-DD813C45F9A7Q38848936-2D0B15C3-6023-4C11-81F2-8FD75DE95A1DQ39249504-BBD02C6A-F37D-44B8-9082-942649B43F22Q39613832-D4BB79DA-439D-49E9-8EE7-C542987DE1CFQ40508641-097C8F00-767D-49C9-885B-66D66A2AAF1BQ40785505-FEB53EEA-32E4-4515-8276-8CDFAB9528A5Q41890756-8AD2D1A0-2538-4F70-9A43-4F9C65F4B3B1Q43693626-EE308138-E0EE-406A-812D-FF735F91E175Q53399282-AB5C6125-9E97-43BC-B4D3-F805CDC165F2Q59120359-8B40C20B-D170-4598-A959-7895C01B42C7
P2860
IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
IL-27 regulates homeostasis of ...... in a murine model of colitis.
@ast
IL-27 regulates homeostasis of ...... in a murine model of colitis.
@en
type
label
IL-27 regulates homeostasis of ...... in a murine model of colitis.
@ast
IL-27 regulates homeostasis of ...... in a murine model of colitis.
@en
prefLabel
IL-27 regulates homeostasis of ...... in a murine model of colitis.
@ast
IL-27 regulates homeostasis of ...... in a murine model of colitis.
@en
P2093
P2860
P356
P1476
IL-27 regulates homeostasis of ...... in a murine model of colitis.
@en
P2093
Amy E Troy
Betsy C Taylor
Christiaan J M Saris
Christopher A Hunter
Colby Zaph
David Artis
Katherine J Guild
P2860
P304
P356
10.4049/JIMMUNOL.0802918
P407
P577
2009-07-13T00:00:00Z